Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer

by Konrad Sopyllo, Andrew M. Erickson, Tuomas Mirtti
Published 2021-02-01

Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression.

by Irena Saarinen, Tuomas Mirtti, Heikki Seikkula, Peter J Boström, Pekka Taimen
Published 2015-01-01

Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer

by Matias Blomqvist, Ilmari Koskinen, Eliisa Löyttyniemi, Tuomas Mirtti, Peter J. Boström, Pekka Taimen
Published 2021-07-01

Three-Dimensional Presentation of Tumor Histopathology: A Model Using Tongue Squamous Cell Carcinoma

by Anne Koivuholma, Katri Aro, Antti Mäkitie, Mika Salmi, Tuomas Mirtti, Jaana Hagström, Timo Atula
Published 2021-01-01

Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma.

by Juhana Rautiola, Anita Lampinen, Tuomas Mirtti, Ari Ristimäki, Heikki Joensuu, Petri Bono, Pipsa Saharinen
Published 2016-01-01

Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer

by Minna Tervahartiala, Pekka Taimen, Tuomas Mirtti, Ilmari Koskinen, Thorsten Ecke, Sirpa Jalkanen, Peter J. Boström
Published 2017-10-01

Activating Mutation (V617F) in the Tyrosine Kinase JAK2 is Absent in Locally-Confined or Castration-Resistant Prostate Cancer

by Lei Gu, Xian-Hua Zhu, Tapio Visakorpi, Kalle Alanen, Tuomas Mirtti, Tina Bocker Edmonston, Marja T. Nevalainen
Published 2010-01-01

Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer.

by Minna M Boström, Heikki Irjala, Tuomas Mirtti, Pekka Taimen, Tommi Kauko, Annika Ålgars, Sirpa Jalkanen, Peter J Boström
Published 2015-01-01

Repeat multiparametric MRI in prostate cancer patients on active surveillance.

by Juho T Eineluoto, Petrus Järvinen, Anu Kenttämies, Tuomas P Kilpeläinen, Hanna Vasarainen, Kevin Sandeman, Andrew Erickson, Tuomas Mirtti, Antti Rannikko
Published 2017-01-01

High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.

by Paula Vainio, John-Patrick Mpindi, Pekka Kohonen, Vidal Fey, Tuomas Mirtti, Kalle A Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin
Published 2012-01-01

Biomarker accompanied significance of mpMRI-visible and invisible lesions for adverse pathology and biochemical recurrence after radical prostatectomy

by J. Eineluoto, K Sandeman, J Pohjonen, K. Sopyllo, S. Nordling, C. Stürenberg, T. Pellinen, M. Matikainen, A. Petas, H. Santti, T. Kilpeläinen, P. Järvinen, A.S. Rannikko, T. Mirtti
Published 2020-07-01

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.

by Kevin Sandeman, Juho T Eineluoto, Joona Pohjonen, Andrew Erickson, Tuomas P Kilpeläinen, Petrus Järvinen, Henrikki Santti, Anssi Petas, Mika Matikainen, Suvi Marjasuo, Anu Kenttämies, Tuomas Mirtti, Antti Rannikko
Published 2020-01-01

Expected impact of MRI related interreader variability on ProScreen prostate cancer screening trial

by R. Hietikko, T.P. Kilpeläinen, A. Kenttämies, J. Ronkainen, K. Ijäs, K. Lind, S. Marjasuo, J. Oksala, O. Oksanen, T. Saarinen, R. Savolainen, K. Taari, T.L.J. Tammela, T. Mirtti, K. Natunen, A. Auvinen, A. Rannikko
Published 2020-07-01

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study

by Ronja Hietikko, Tuomas P. Kilpeläinen, Anu Kenttämies, Johanna Ronkainen, Kirsty Ijäs, Kati Lind, Suvi Marjasuo, Juha Oksala, Outi Oksanen, Tuomas Saarinen, Ritja Savolainen, Kimmo Taari, Teuvo L. J. Tammela, Tuomas Mirtti, Kari Natunen, Anssi Auvinen, Antti Rannikko
Published 2020-10-01

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

by Victor Cervera-Carrascon, Dafne C.A. Quixabeira, Joao Manuel Santos, Riikka Havunen, Sadia Zafar, Otto Hemminki, Camilla Heiniö, Eleonora Munaro, Mikko Siurala, Suvi Sorsa, Tuomas Mirtti, Petrus Järvinen, Markus Mildh, Harry Nisen, Antti Rannikko, Marjukka Anttila, Anna Kanerva, Akseli Hemminki
Published 2020-01-01

Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial.

by Ivan Jambor, Janne Verho, Otto Ettala, Juha Knaapila, Pekka Taimen, Kari T Syvänen, Aida Kiviniemi, Esa Kähkönen, Ileana Montoya Perez, Marjo Seppänen, Antti Rannikko, Outi Oksanen, Jarno Riikonen, Sanna Mari Vimpeli, Tommi Kauko, Harri Merisaari, Markku Kallajoki, Tuomas Mirtti, Tarja Lamminen, Jani Saunavaara, Hannu J Aronen, Peter J Boström
Published 2019-06-01